Market closedNon-fractional

Stereotaxis/STXS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Stereotaxis

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

Ticker

STXS

Sector

Healthcare

Trading on

AMEX

Industry

Health Care Equipment and Supplies

Headquarters

Saint Louis, United States

Employees

122

Stereotaxis Metrics

BasicAdvanced
$163M
Market cap
-
P/E ratio
-$0.26
EPS
1.53
Beta
-
Dividend rate
$163M
1.53
2.428
1.68
24.687
26.898
-29.07%
-80.58%
6.023
11.18
11.18
-18.764
-2.01%
-5.13%
-2.78%
36.56%

What the Analysts think about Stereotaxis

Analyst Ratings

Majority rating from 6 analysts.
Buy

Stereotaxis Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-66.17% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$6.8M
51.11%
Net income
-$4.5M
-10.00%
Profit margin
-66.17%
-40.45%

Stereotaxis Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.23%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.07
-$0.07
-$0.07
-$0.06
-
Expected
-$0.07
-$0.06
-$0.07
-$0.06
-$0.05
Surprise
-3.05%
15.51%
6.06%
-3.23%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Stereotaxis stock?

Stereotaxis (STXS) has a market cap of $163M as of July 23, 2024.

What is the P/E ratio for Stereotaxis stock?

The price to earnings (P/E) ratio for Stereotaxis (STXS) stock is 0 as of July 23, 2024.

Does Stereotaxis stock pay dividends?

No, Stereotaxis (STXS) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next Stereotaxis dividend payment date?

Stereotaxis (STXS) stock does not pay dividends to its shareholders.

What is the beta indicator for Stereotaxis?

Stereotaxis (STXS) has a beta rating of 1.53. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Stereotaxis stock

Buy or sell Stereotaxis stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing